<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1D3C9ADE-5860-4017-88E9-BCDCD95A7CBA"><gtr:id>1D3C9ADE-5860-4017-88E9-BCDCD95A7CBA</gtr:id><gtr:name>University of Bath</gtr:name><gtr:address><gtr:line1>Claverton Down</gtr:line1><gtr:city>Bath</gtr:city><gtr:postCode>BA2 7AY</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0517AC0E-EF12-4F19-A6DD-6406FF2123A2"><gtr:id>0517AC0E-EF12-4F19-A6DD-6406FF2123A2</gtr:id><gtr:name>Life Technologies</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/41434B79-7F01-4924-85CB-95E8C52DD7EA"><gtr:id>41434B79-7F01-4924-85CB-95E8C52DD7EA</gtr:id><gtr:name>Aintree University Hospitals</gtr:name><gtr:address><gtr:line1>Longmoor Lane</gtr:line1><gtr:postCode>L9 7AL</gtr:postCode><gtr:region>North West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:department>Biomedical Sciences</gtr:department><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1D3C9ADE-5860-4017-88E9-BCDCD95A7CBA"><gtr:id>1D3C9ADE-5860-4017-88E9-BCDCD95A7CBA</gtr:id><gtr:name>University of Bath</gtr:name><gtr:address><gtr:line1>Claverton Down</gtr:line1><gtr:city>Bath</gtr:city><gtr:postCode>BA2 7AY</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0517AC0E-EF12-4F19-A6DD-6406FF2123A2"><gtr:id>0517AC0E-EF12-4F19-A6DD-6406FF2123A2</gtr:id><gtr:name>Life Technologies</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/41434B79-7F01-4924-85CB-95E8C52DD7EA"><gtr:id>41434B79-7F01-4924-85CB-95E8C52DD7EA</gtr:id><gtr:name>Aintree University Hospitals</gtr:name><gtr:address><gtr:line1>Longmoor Lane</gtr:line1><gtr:postCode>L9 7AL</gtr:postCode><gtr:region>North West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/FE6E2523-AFDD-4BC9-93E2-561E1B55AFE1"><gtr:id>FE6E2523-AFDD-4BC9-93E2-561E1B55AFE1</gtr:id><gtr:firstName>John</gtr:firstName><gtr:surname>Neoptolemos</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/71087E01-D085-4094-80C8-484FCF5B21D1"><gtr:id>71087E01-D085-4094-80C8-484FCF5B21D1</gtr:id><gtr:firstName>Kevin</gtr:firstName><gtr:surname>Park</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/4595878D-6166-4746-9780-0DD6A5B8F304"><gtr:id>4595878D-6166-4746-9780-0DD6A5B8F304</gtr:id><gtr:firstName>Graham</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Dockray</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/736902BB-EB08-43A0-B758-5993530E6ABB"><gtr:id>736902BB-EB08-43A0-B758-5993530E6ABB</gtr:id><gtr:firstName>Robert</gtr:firstName><gtr:otherNames>D</gtr:otherNames><gtr:surname>Burgoyne</gtr:surname><gtr:orcidId>0000-0002-9219-0387</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/375C4076-CC65-4A66-A0A7-25F6C7C73E03"><gtr:id>375C4076-CC65-4A66-A0A7-25F6C7C73E03</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:surname>O'Neill</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/5772C072-313B-427A-BB34-FE2437834B08"><gtr:id>5772C072-313B-427A-BB34-FE2437834B08</gtr:id><gtr:firstName>Alastair</gtr:firstName><gtr:surname>Watson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/3C92C9EF-E092-439E-BB0B-63E3A660540D"><gtr:id>3C92C9EF-E092-439E-BB0B-63E3A660540D</gtr:id><gtr:firstName>Dean</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Naisbitt</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/B0A00BC6-C8F5-4F7A-B469-7366B58031D0"><gtr:id>B0A00BC6-C8F5-4F7A-B469-7366B58031D0</gtr:id><gtr:firstName>Alan</gtr:firstName><gtr:surname>Morgan</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/DFCB4295-40A1-4065-9A90-983FC286D23B"><gtr:id>DFCB4295-40A1-4065-9A90-983FC286D23B</gtr:id><gtr:firstName>Tim</gtr:firstName><gtr:surname>Green</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/984254AD-AFAE-4097-9066-8EEC556BA796"><gtr:id>984254AD-AFAE-4097-9066-8EEC556BA796</gtr:id><gtr:firstName>John</gtr:firstName><gtr:otherNames>Roland</gtr:otherNames><gtr:surname>Jenkins</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/77F021F2-CB59-421B-9A71-664FE2218FBD"><gtr:id>77F021F2-CB59-421B-9A71-664FE2218FBD</gtr:id><gtr:firstName>Munir</gtr:firstName><gtr:surname>Pirmohamed</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C0D99921-7081-40CB-882E-AC94FF39DE85"><gtr:id>C0D99921-7081-40CB-882E-AC94FF39DE85</gtr:id><gtr:firstName>Neil</gtr:firstName><gtr:otherNames>Reymond</gtr:otherNames><gtr:surname>Kitteringham</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/0878E54D-6D83-4812-A807-EF2C5A2E1782"><gtr:id>0878E54D-6D83-4812-A807-EF2C5A2E1782</gtr:id><gtr:firstName>Eithne</gtr:firstName><gtr:surname>Costello</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0301157"><gtr:id>83193121-F17F-45B5-8319-8CF2A22AE675</gtr:id><gtr:title>Quantitative high throughput proteomics for biomedical research</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0301157</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2008-03-20</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-03-21</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>313110</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Aintree University Hospital NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Head &amp;amp; neck cancer / Terry Jones</gtr:description><gtr:id>85C7397B-0761-4CD5-AA1B-96C6A02B264A</gtr:id><gtr:impact>PhD thesis pending for a Clinical Research Fellow (Paul Goodyear).</gtr:impact><gtr:outcomeId>49D34AE7005-1</gtr:outcomeId><gtr:partnerContribution>Contribution of patient samples for protein profiling.</gtr:partnerContribution><gtr:piContribution>Technological expertise to enable identification of proteins involved in diagnosis of head and neck cyst versus head and neck cancer.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Liverpool</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Medical Microbiology</gtr:department><gtr:description>Burkholderia / John Smalley</gtr:description><gtr:id>65A29430-7F7D-4713-9336-CBBB76075E98</gtr:id><gtr:impact>PMID: 17371508</gtr:impact><gtr:outcomeId>A87A8F7E83B-1</gtr:outcomeId><gtr:piContribution>Technological expertise to enable identification of proteins involved in infection by burkholderia in cystic fibrosis patients.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Liverpool</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Medicine and Surgery</gtr:department><gtr:description>Tumour development / Mark Boyd</gtr:description><gtr:id>B2061A55-46FB-4CC1-9417-170320A004AA</gtr:id><gtr:impact>PMID: 18451149 Collaboration continues looking for binding partners of MDM2 in the regulation of cell cycle progression</gtr:impact><gtr:outcomeId>E09514F2275-1</gtr:outcomeId><gtr:piContribution>Technological expertise to enable identification of proteins involved in tumour development.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Life Technologies</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Applied Biosystems</gtr:department><gtr:description>Mass Spectrometry Interactions</gtr:description><gtr:id>946AC2A0-53A5-4A2E-BB33-65EA9D36B92B</gtr:id><gtr:impact>19041286 16479536 Also produced technical notes on quantitation of proteins</gtr:impact><gtr:outcomeId>1170AD11899-1</gtr:outcomeId><gtr:partnerContribution>Technical expertise in advanced mass spectrometry and associated software.</gtr:partnerContribution><gtr:piContribution>Feedback on technical issues with mass spectrometry equipment. Guidance as to the future direction of software development.</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bath</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Chemistry</gtr:department><gtr:description>Drug toxicity / Andrew Stachulski</gtr:description><gtr:id>A856DF8F-73CC-46DD-BADE-464E6C1637E8</gtr:id><gtr:impact>PMID: 17985860</gtr:impact><gtr:outcomeId>0C183B44F51-1</gtr:outcomeId><gtr:partnerContribution>Chemical expertise has made significant contributions to our understanding of protein biochemistry in adverse drug reactions. They have also been involved in synthesising reagents for protein quantification.</gtr:partnerContribution><gtr:piContribution>Ongoing long term collaboration to elucidate mechanisms of drug toxicity. We have provided expertise in protein mass spectrometry to complement their expertise in low molecular weight mass spectrometry.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>263394</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR Project grant</gtr:description><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>4FDAA9E0-BE74-416C-87A3-4D579B6C374C</gtr:id><gtr:outcomeId>F5A5AD7343F0</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>123405</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK Project Grant - combined genetic and proteomic screening for early detection of pancreatic cancer</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>3D358D99-A650-4A7D-BEA2-90A194F45CBF</gtr:id><gtr:outcomeId>B3FD5C6F1F70</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1209270</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>SENSIT-IV Project grant</gtr:description><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>B64C7FD3-F7FB-44AA-A3C1-0351A3CD7B71</gtr:id><gtr:outcomeId>D43B7831CEA0</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3647630</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Centre Grant</gtr:description><gtr:end>2015-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G0700654</gtr:fundingRef><gtr:id>DFBCF7E8-1BC4-47C6-A128-06C66FC01081</gtr:id><gtr:outcomeId>6D177C585020</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1300000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Liverpool CRUK Centre</gtr:description><gtr:end>2014-03-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>6CB8A00D-8503-4802-8E0D-6273DC44A997</gtr:id><gtr:outcomeId>4FB18497C690</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>111147</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NWCR Project grant - Neil Kitteringham</gtr:description><gtr:end>2016-02-02</gtr:end><gtr:fundingOrg>North West Cancer Research (NWCR)</gtr:fundingOrg><gtr:id>D9A69A9F-F655-4AF4-A427-990182F156BC</gtr:id><gtr:outcomeId>C47B8983F9B0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-02-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Method for the absolute quanitification of proteins using stable isotope labels.</gtr:description><gtr:id>C9969FFA-1675-43B7-BCFA-96D5C548010F</gtr:id><gtr:impact>We have continued to develop and exploit this type of approach for the analysis of cancer progression, metastasis and drug toxicity.</gtr:impact><gtr:outcomeId>D5779752CB2</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Absolute quantification of protein</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>3F865D60-1805-4A98-9996-5A527307E5D0</gtr:id><gtr:title>MDM2 regulates dihydrofolate reductase activity through monoubiquitination.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1fc8593fcee39c27df0108b010762ab2"><gtr:id>1fc8593fcee39c27df0108b010762ab2</gtr:id><gtr:otherNames>Maguire M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>B313940DC4B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>387C34D3-A8DC-4099-A4C8-BF1CE870C6D7</gtr:id><gtr:title>Multiple reaction monitoring for quantitative biomarker analysis in proteomics and metabolomics.</gtr:title><gtr:parentPublicationTitle>Journal of chromatography. B, Analytical technologies in the biomedical and life sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b54d3a073b40a96717f37e2ec6921ce1"><gtr:id>b54d3a073b40a96717f37e2ec6921ce1</gtr:id><gtr:otherNames>Kitteringham NR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1570-0232</gtr:issn><gtr:outcomeId>2541D767ECC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34E43100-1606-4623-8901-47A8ADF2498F</gtr:id><gtr:title>Pancreatic cancer cells overexpress gelsolin family-capping proteins, which contribute to their cell motility.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e43a60537bdb5b412a969efecdeb653"><gtr:id>0e43a60537bdb5b412a969efecdeb653</gtr:id><gtr:otherNames>Thompson CC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>9A7967F292B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63E99781-C567-4FF8-B418-F1F321E99F27</gtr:id><gtr:title>Characterization of a bifunctional catalase-peroxidase of Burkholderia cenocepacia.</gtr:title><gtr:parentPublicationTitle>FEMS immunology and medical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28b2586ac753aac4f53b2ff046ff3cdf"><gtr:id>28b2586ac753aac4f53b2ff046ff3cdf</gtr:id><gtr:otherNames>Charalabous P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0928-8244</gtr:issn><gtr:outcomeId>4456451863A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>45C869F1-B1C4-4D51-A2C8-3252751E18AA</gtr:id><gtr:title>Use of proteomics for the discovery of early markers of drug toxicity.</gtr:title><gtr:parentPublicationTitle>Expert opinion on drug metabolism &amp; toxicology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40a8d3873b8758ee571d25f091499bfc"><gtr:id>40a8d3873b8758ee571d25f091499bfc</gtr:id><gtr:otherNames>Collins BC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1742-5255</gtr:issn><gtr:outcomeId>6539506A72C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E022FD8F-DA12-4E54-86DB-0AC31A78D902</gtr:id><gtr:title>The expression of S100A8 in pancreatic cancer-associated monocytes is associated with the Smad4 status of pancreatic cancer cells.</gtr:title><gtr:parentPublicationTitle>Proteomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa18d8eb161cb4dbb06e2d38228ef08d"><gtr:id>aa18d8eb161cb4dbb06e2d38228ef08d</gtr:id><gtr:otherNames>Sheikh AA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1615-9853</gtr:issn><gtr:outcomeId>951708AA383</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7A5F4BF-859D-4C77-BE5A-E07BA33468AE</gtr:id><gtr:title>The hepatotoxic metabolite of acetaminophen directly activates the Keap1-Nrf2 cell defense system.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6df89b6324556c806bdd3836640b9da3"><gtr:id>6df89b6324556c806bdd3836640b9da3</gtr:id><gtr:otherNames>Copple IM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn><gtr:outcomeId>C1053E14193</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1AA1DB6-032E-4358-9DE6-C8E6AEF4E92E</gtr:id><gtr:title>Cyclization of the acyl glucuronide metabolite of a neutral endopeptidase inhibitor to an electrophilic glutarimide: synthesis, reactivity, and mechanistic analysis.</gtr:title><gtr:parentPublicationTitle>Journal of medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b7b1dadfe0840b56df4eb942edf8fc5"><gtr:id>9b7b1dadfe0840b56df4eb942edf8fc5</gtr:id><gtr:otherNames>Meng X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-2623</gtr:issn><gtr:outcomeId>4A417727FB3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>35BE0117-1B69-4F3A-A5A7-70F653254B25</gtr:id><gtr:title>Glutathione-S-transferase pi as a model protein for the characterisation of chemically reactive metabolites.</gtr:title><gtr:parentPublicationTitle>Proteomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b23415e6bcb1811052d6abb2f91368f8"><gtr:id>b23415e6bcb1811052d6abb2f91368f8</gtr:id><gtr:otherNames>Jenkins RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1615-9853</gtr:issn><gtr:outcomeId>EF2E4E110F2</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0301157</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>12A0B409-0C29-4056-9092-2D86E44017F3</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.4  Methodologies and measurements</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>